GlassScriptPhysician profile
Phillip C Longnecker
NPI 1982989646
$1,326.05
in general payments reported to CMS, 2019-2025
18 companies · $18.95 in 2025
The $18.95 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $905 · 2022: $360 · 2023: $24.37 · 2024: $17.31 · 2025: $18.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $60.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $60.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $260.56 | 2021-2022 | |
| Novo Nordisk INC | $204.14 | 2021-2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.97 | 2021-2022 | |
| Abbvie INC. | $108.09 | 2021-2024 | |
| Pfizer INC. | $91.63 | 2021 | |
| Lilly USA, LLC | $87.08 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $79.89 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $65.43 | 2021-2022 | |
| Genentech USA, INC. | $60.76 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $45.44 | 2021 | |
| Boston Scientific Corporation | $24.37 | 2023 | Varithena Administration Pack |
| Alkermes, INC. | $20.91 | 2021 | |
| Xeris Pharmaceuticals, INC. | $17.79 | 2022 | |
| Abbott Laboratories | $15.59 | 2021 | |
| Amarin Pharma, INC. | $14.47 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $14.21 | 2021 | |
| Merck Sharp & Dohme LLC | $13.01 | 2021 | |
| Sanofi Pasteur INC. | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Longnecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.